3 results
Approved WMOCompleted
To evaluate the effects of COS with tamoxifen or letrozole compared to standard COS, on oocytes retrieved.
Approved WMOCompleted
To determine the safety and tolerability of L19-IL2 combined with SABR.
Approved WMOCompleted
To test whether monthly infusions (every four weeks) of intravenous Flebogamma® 5% DIF in a 1 year treatment period in PPS subjects are superior to placebo by assessing physical performance, as measured by 2MWD.For Stage 1, to select the optimal…